• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Heart Failure/Congestive Heart Failure (4446)
Event Date 12/01/2020
Event Type  Death  
Manufacturer Narrative
The event date has been estimated.
 
Event Description
It was reported that the patient was placed in hospice care in (b)(6) 2020 following issues with right heart failure.The right ventricular dysfunction started on (b)(6) 2021 and the percutaneous rvad was inserted on (b)(6) 2021.The patient had a coronary artery intervention with dye.After the procedure the patient had to be placed on cardiac resynchronization therapy (crt) due to the dye affecting the patient's kidneys.It was also believed that the patient got crt due to constant ventricular tachycardia episodes and right ventricular failure the patient was then trached and vented.The patient required rvad support and once it was discontinued the patient declined requiring hospice care.The family withdrew treatment on (b)(6) 2021.The pump will not be returned and there will not be an autopsy.The death was not considered to be device related and the device operated as expected.
 
Event Description
It was reported that the percutaneous right ventricular assist device (rvad) cannula via right internal jugular vein (protek duo 31f veno-venous dual lumen cannula) was inserted under fluoroscopic guidance on (b)(6) 2021.A veno-venous (v-v) ecmo for right-side of heart was inserted and the right femoral venous quinton catheter for continuous renal replacement therapy (crrt) was inserted.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct relationship between heartmate 3 left ventricular assist system (lvas), serial number (b)(6), and the reported right heart failure, cardiac arrhythmia, and renal dysfunction could not be conclusively determined through this evaluation.The heartmate 3 lvas instructions for use (ifu) lists right heart failure and cardiac arrhythmia as adverse events that may be associated with the use of the heartmate 3 left ventricular assist system.This document also lists arrhythmia as a potential late postimplant complication.The relevant sections of the device history records for (b)(6), were reviewed and showed no deviations from manufacturing or quality assurance specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key11373046
MDR Text Key233302230
Report Number2916596-2021-00695
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 03/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/28/2022
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number7582681
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/29/2021
Initial Date FDA Received02/24/2021
Supplement Dates Manufacturer Received03/08/2021
Supplement Dates FDA Received03/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age73 YR
Patient Weight67
-
-